Clinical Trials Directory

Trials / Completed

CompletedNCT04466696

Feasibility of ERAS Protocol in T4 Colorectal Cancer Patients

Status
Completed
Phase
Study type
Observational
Enrollment
82 (actual)
Sponsor
University of Rome Tor Vergata · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Patients diagnosed with T4 colorectal cancer represent a specific subgroup of colorectal patients, frequently composed of fragile patients whose advanced nature of the disease often requires a multi organ resection by an open surgery approach and frequently leads to higher intra/postoperative complication.Those characteristics makes them to be considered less suitable for ERAS protocol, especially regarding an expected difficult compliance to postoperative items. The impact of enhanced recovery program on postoperative outcomes in this subset of patients has never been addressed in literature, in fact most of studies either excluded T4 patients due to higher rates of complication or adopted an homogeneous patient sampling analizing all stage colorectal cancer together. Our aim is to investigate the feasibility of ERAS protocol in T4 colorectal patient, primary outcome was to compare postoperative lenght of stay between T4 colorectal patients treated with ERAS protcol and those treated with standard of care.

Conditions

Interventions

TypeNameDescription
BEHAVIORALERAS protocolitems of ERAS protocol applied

Timeline

Start date
2016-01-01
Primary completion
2020-05-30
Completion
2020-07-07
First posted
2020-07-10
Last updated
2020-12-29

Source: ClinicalTrials.gov record NCT04466696. Inclusion in this directory is not an endorsement.

Feasibility of ERAS Protocol in T4 Colorectal Cancer Patients (NCT04466696) · Clinical Trials Directory